With the sustained rapid cellular proliferation and a high metabolic rate of tumor cells, the rapid development of new vascular networks is often required, which is driven by angiogenic factors such as the vascular endothelial growth factor (VEGF) family, hypoxia-inducible factors (HIFs), and fibroblast growth factors (FGFs) (7). The gene discussed is VEGFA; the disease is neoplasm.